Literature DB >> 22515100

Silver-loaded biomimetic hydroxyapatite grafted poly(epsilon-caprolactone) composite nanofibers: a cytotoxicity study.

R Nirmala1, Hyung-Sub Kang, Hye-Min Park, R Navamathavan, In Soo Jeong, Hak Yong Kim.   

Abstract

We report on poly(epsilon-caprolactone) (PCL) containing biomimetic hydroxyapatite (HA) and hydroxyapatite-silver (HA-Ag) composite nanofibers prepared via an electrospinning process for the biomedical applications. The morphology, structure and thermal properties of the PCL, PCL/HA and PCL/HA-Ag composite nanofibers were characterized by scanning electron microscopy (SEM), transmission electron microscopy (TEM), energy dispersive X-ray (EDX) spectroscopy, X-ray diffraction (XRD) and thermogravimetry (TGA). SEM images revealed that the nanofibers were well-oriented and incorporated the HA-Ag nanoparticles well. The adhesion, viability and proliferation properties of composite nanofibers and differentiation of osteoblast were carried out to study the in vitro cell compatibility of the PCL/HA/HA-Ag composite nanofibers. Our results showed that pristine PCL and PCL/HA composite nanofibers scaffold can be utilized for the bone regeneration applications, however, PCL/HA-Ag composite nanofibers results in mild cytotoxic effect to human cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515100     DOI: 10.1166/jbn.2012.1359

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  2 in total

1.  Glutaraldehyde cross-linking of amniotic membranes affects their nanofibrous structures and limbal epithelial cell culture characteristics.

Authors:  Jui-Yang Lai; David Hui-Kang Ma
Journal:  Int J Nanomedicine       Date:  2013-10-31

2.  Cytotoxicity and Synergistic Effect of Biogenically Synthesized Ternary Therapeutic Nano Conjugates Comprising Plant Active Principle, Silver and Anticancer Drug on MDA-MB-453 Breast Cancer Cell Line.

Authors:  Arjunan Karuppiah; Ravikumar Rajan; Muthiah Ramanathan; Arumugam Nagarajan
Journal:  Asian Pac J Cancer Prev       Date:  2020-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.